Jon Snodgres — Chief Financial Officer and Secretary at Repligen Corporation

Mr. Jon K. Snodgres has been Chief Financial Officer of Repligen Corporation since July 15, 2014 and serves its Secretary. Mr. Snodgres joined Maquet Cardiovascular as Chief Financial Officer in 2009. There, in addition to P&L, balance sheet and cash flow responsibility, he was a key participant in growth planning and profit improvement strategies. During his tenure with Maquet, Repligen's cardiovascular business significantly increased sales and earnings through acquisitions, organic growth, portfolio management, pricing discipline and restructuring actions. While with Thermo Fisher Scientific, as Laboratory Products Group Vice President of Finance from 2005 to 2008, Mr. Snodgres helped drive profit improvements through acquisition, consolidation and facility optimization, as well as the implementation of analytical tools and processes that enhanced decision making. He has also served as Vice President of Financial Operations for Newport Corporation, a laser and photonics solutions provider. He began his career in finance at AlliedSignal/Honeywell International. Mr. Snodgres received a Bachelor of Science degree in Business Administration, Finance from Northern Arizona University.